 | • レポートコード：QYR2104Z0492 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、在宅薬物乱用（DOA）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（検査カップ、検査ディップカード、検査ストリップ、その他）、用途別市場規模（尿、唾液、毛髪、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・在宅薬物乱用（DOA）検査の市場動向 ・企業の競争状況、市場シェア ・在宅薬物乱用（DOA）検査の種類別市場規模（検査カップ、検査ディップカード、検査ストリップ、その他） ・在宅薬物乱用（DOA）検査の用途別市場規模（尿、唾液、毛髪、その他） ・在宅薬物乱用（DOA）検査の北米市場規模2016-2027（アメリカ、カナダ） ・在宅薬物乱用（DOA）検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・在宅薬物乱用（DOA）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・在宅薬物乱用（DOA）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・在宅薬物乱用（DOA）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（UCP Biosciences、Orient New Life Medical、Express Diagnostics Int’l、Assure Tech (Hangzhou)、Psychemedics Corporation、Confirm BioSciences、Phamatech、Home Health (U.K.) Ltd.、Quest Products） ・結論 |
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Market Analysis and Insights: Global At-Home Drug of Abuse (DOA) Testing Market
The global At-Home Drug of Abuse (DOA) Testing market size is projected to reach US$ 779.7 million by 2026, from US$ 381.5 million in 2019, at a CAGR of 10.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global At-Home Drug of Abuse (DOA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global At-Home Drug of Abuse (DOA) Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global At-Home Drug of Abuse (DOA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global At-Home Drug of Abuse (DOA) Testing market.
Global At-Home Drug of Abuse (DOA) Testing Scope and Market Size
At-Home Drug of Abuse (DOA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global At-Home Drug of Abuse (DOA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Test Cups
Test Dip Cards
Test Strips
Others
Segment by Application
Urine
Saliva
Hair
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Test Cups
1.2.3 Test Dip Cards
1.2.4 Test Strips
1.2.5 Others
1.3 Market by Application
1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Urine
1.3.3 Saliva
1.3.4 Hair
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2016-2027)
2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Regions
2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Share by Regions (2016-2021)
2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2022-2027)
2.3 At-Home Drug of Abuse (DOA) Testing Industry Dynamic
2.3.1 At-Home Drug of Abuse (DOA) Testing Market Trends
2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2016-2021)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2021)
3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2020
3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2016-2021)
4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2022-2027)
5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2016-2021)
5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type
6.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
6.2.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
6.2.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application
6.3.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
6.3.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
6.3.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
6.4.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
6.4.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type
7.2.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
7.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
7.2.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application
7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
7.3.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
7.3.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
7.4.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
7.4.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type
8.2.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application
8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
8.4.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type
9.2.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
9.2.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
9.2.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application
9.3.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
9.3.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
9.3.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country
9.4.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
9.4.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type
10.2.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application
10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
10.4.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 UCP Biosciences
11.1.1 UCP Biosciences Company Details
11.1.2 UCP Biosciences Business Overview
11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.1.5 UCP Biosciences Recent Development
11.2 Orient New Life Medical
11.2.1 Orient New Life Medical Company Details
11.2.2 Orient New Life Medical Business Overview
11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.2.5 Orient New Life Medical Recent Development
11.3 Express Diagnostics Int’l
11.3.1 Express Diagnostics Int’l Company Details
11.3.2 Express Diagnostics Int’l Business Overview
11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.3.5 Express Diagnostics Int’l Recent Development
11.4 Assure Tech (Hangzhou)
11.4.1 Assure Tech (Hangzhou) Company Details
11.4.2 Assure Tech (Hangzhou) Business Overview
11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.4.5 Assure Tech (Hangzhou) Recent Development
11.5 Psychemedics Corporation
11.5.1 Psychemedics Corporation Company Details
11.5.2 Psychemedics Corporation Business Overview
11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.5.5 Psychemedics Corporation Recent Development
11.6 Confirm BioSciences
11.6.1 Confirm BioSciences Company Details
11.6.2 Confirm BioSciences Business Overview
11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.6.5 Confirm BioSciences Recent Development
11.7 Phamatech
11.7.1 Phamatech Company Details
11.7.2 Phamatech Business Overview
11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.7.5 Phamatech Recent Development
11.8 Home Health (U.K.) Ltd.
11.8.1 Home Health (U.K.) Ltd. Company Details
11.8.2 Home Health (U.K.) Ltd. Business Overview
11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.8.5 Home Health (U.K.) Ltd. Recent Development
11.9 Quest Products
11.9.1 Quest Products Company Details
11.9.2 Quest Products Business Overview
11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
11.9.5 Quest Products Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Test Cups
Table 3. Key Players of Test Dip Cards
Table 4. Key Players of Test Strips
Table 5. Key Players of Others
Table 6. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global At-Home Drug of Abuse (DOA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2016-2021)
Table 10. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2022-2027)
Table 12. At-Home Drug of Abuse (DOA) Testing Market Trends
Table 13. At-Home Drug of Abuse (DOA) Testing Market Drivers
Table 14. At-Home Drug of Abuse (DOA) Testing Market Challenges
Table 15. At-Home Drug of Abuse (DOA) Testing Market Restraints
Table 16. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players (2016-2021)
Table 18. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2020)
Table 19. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
Table 23. Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2016-2021)
Table 27. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2016-2021)
Table 31. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. UCP Biosciences Company Details
Table 64. UCP Biosciences Business Overview
Table 65. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product
Table 66. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 67. UCP Biosciences Recent Development
Table 68. Orient New Life Medical Company Details
Table 69. Orient New Life Medical Business Overview
Table 70. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product
Table 71. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 72. Orient New Life Medical Recent Development
Table 73. Express Diagnostics Int’l Company Details
Table 74. Express Diagnostics Int’l Business Overview
Table 75. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product
Table 76. Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 77. Express Diagnostics Int’l Recent Development
Table 78. Assure Tech (Hangzhou) Company Details
Table 79. Assure Tech (Hangzhou) Business Overview
Table 80. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product
Table 81. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 82. Assure Tech (Hangzhou) Recent Development
Table 83. Psychemedics Corporation Company Details
Table 84. Psychemedics Corporation Business Overview
Table 85. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product
Table 86. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 87. Psychemedics Corporation Recent Development
Table 88. Confirm BioSciences Company Details
Table 89. Confirm BioSciences Business Overview
Table 90. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product
Table 91. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 92. Confirm BioSciences Recent Development
Table 93. Phamatech Company Details
Table 94. Phamatech Business Overview
Table 95. Phamatech At-Home Drug of Abuse (DOA) Testing Product
Table 96. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 97. Phamatech Recent Development
Table 98. Home Health (U.K.) Ltd. Company Details
Table 99. Home Health (U.K.) Ltd. Business Overview
Table 100. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 101. Home Health (U.K.) Ltd. Recent Development
Table 102. Quest Products Company Details
Table 103. Quest Products Business Overview
Table 104. Quest Products At-Home Drug of Abuse (DOA) Testing Product
Table 105. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
Table 106. Quest Products Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global At-Home Drug of Abuse (DOA) Testing Market Share by Type: 2020 VS 2027
Figure 2. Test Cups Features
Figure 3. Test Dip Cards Features
Figure 4. Test Strips Features
Figure 5. Others Features
Figure 6. Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2020 VS 2027
Figure 7. Urine Case Studies
Figure 8. Saliva Case Studies
Figure 9. Hair Case Studies
Figure 10. Others Case Studies
Figure 11. At-Home Drug of Abuse (DOA) Testing Report Years Considered
Figure 12. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2022-2027)
Figure 16. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2020
Figure 17. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2020
Figure 19. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
Figure 23. North America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
Figure 24. North America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
Figure 25. United States At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
Figure 29. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
Figure 30. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
Figure 31. Germany At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Region (2016-2027)
Figure 41. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
Figure 49. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
Figure 50. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
Figure 51. Mexico At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
Figure 57. Turkey At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UCP Biosciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 61. Orient New Life Medical Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 62. Express Diagnostics Int’l Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 63. Assure Tech (Hangzhou) Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 64. Psychemedics Corporation Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 65. Confirm BioSciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 66. Phamatech Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 67. Home Health (U.K.) Ltd. Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 68. Quest Products Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の薬物乱用（DOA）検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug of Abuse (DOA) Testing Market The global Drug of Abuse (DOA) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…- 世界の薬物乱用（DOA）検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug of Abuse (DOA) Testing Market The global Drug of Abuse (DOA) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の薬物乱用検査サービス市場規模・現状・予測（2021年-2027年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 世界の薬物乱用検査市場規模・現状・予測（2021年-2027年） Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, …
- 世界の薬物乱用検査市場規模・現状・予測（2021年-2027年） Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Testing detects substances not normally found in the body, with the exception of some hormones and steroids measured as part of sports testing. Illegal drug is non…